Payen, Emmanuel
Brigham and Women's Hospital · Lurie Children's Hospital · The University of Sydney · University of California, Los Angeles · University of California, San Francisco · Mahidol University · Institut Necker Enfants Malades · Assistance Publique – Hôpitaux de Paris · University of Pennsylvania · Stanford University
8 papers on CoChatORCID 0000-0002-1329-2327
Most cited papers
- Verified
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science
Virus-based gene therapy researchLysosomal Storage Disorders Research
Cited by 1,508
- Verified
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Cavazzana-Calvo, M., Payen, E., Negre, O., Wang, G., Hehir, K., Fusil, F., Down, J., Denaro, M., Brady, T., Westerman, K., et al. (2010) · Nature
Virus-based gene therapy researchHemoglobinopathies and Related Disorders
Cited by 1,276
- Verified
Gene therapy in a patient with sickle cell disease
Ribeil, J.-A., Hacein-Bey-Abina, S., Payen, E., Magnani, A., Semeraro, M., Magrin, E., Caccavelli, L., Neven, B., Bourget, P., El Nemer, W., et al. (2017) · New England Journal of Medicine
Virus-based gene therapy researchHemoglobinopathies and Related Disorders
Cited by 696
- Verified
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
Thompson, A. A., Walters, M. C., Kwiatkowski, J., Rasko, J. E. J., Ribeil, J.-A., Hongeng, S., Magrin, E., Schiller, G. J., Payen, E., Semeraro, M., et al. (2018) · New England Journal of Medicine
Virus-based gene therapy researchHemoglobinopathies and Related Disorders
Cited by 684
- Verified
Correction of sickle cell disease in transgenic mouse models by gene therapy
Pawliuk, R., Westerman, K. A., Fabry, M. E., Payen, E., Tighe, R., Bouhassira, E. E., Acharya, S. A., Ellis, J., London, I. M., Eaves, C. J., et al. (2001) · Science
Virus-based gene therapy researchHemoglobinopathies and Related Disorders
Cited by 579
- Verified
An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia
Dussiot, M., Maciel, T. T., Fricot, A., Chartier, C., Negre, O., Veiga, J., Grapton, D., Paubelle, E., Payen, E., Beuzard, Y., et al. (2014) · Nature Medicine
Hemoglobinopathies and Related DisordersIron Metabolism and Disorders
Cited by 279
- Verified
Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β A(T87Q) - Globin Gene
Negre, O., Eggimann, A.-V., Beuzard, Y., Ribeil, J.-A., Bourget, P., Borwornpinyo, S., Hongeng, S., Hacein-Bey, S., Cavazzana, M., Leboulch, P., et al. (2016) · Human Gene Therapy
Virus-based gene therapy researchHemoglobinopathies and Related Disorders
Cited by 159
- Verified
Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-Thalassemia and Sickle Cell Disease
Negre, O., Bartholomae, C., Beuzard, Y., Cavazzana, M., Christiansen, L., Courne, C., Deichmann, A., Denaro, M., Dreuzy, E., Finer, M., et al. (2014) · Current Gene Therapy
Virus-based gene therapy researchHemoglobinopathies and Related Disorders
Cited by 126
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free